Earnings Call Insights: Lineage Cell Therapeutics (LCTX) Q1 2025 Management View CEO Brian Culley highlighted the progress of OpRegen, noting its differentiation from current anti-complement ...

New study outlines how brain cancer cells take mitochondria from healthy cells to grow and survive . Cleveland Clinic. Journal Nature Cancer DOI 10.1038/s43018-023-00556-5. Keywords ...

Brainstorm Cell Therapeutics management conveyed that FDA clearance for the pivotal Phase 3b ALS trial represents a major milestone, with operational infrastructure and clinical site engagement ...

CARLSBAD, Calif. - Lineage Cell Therapeutics (NYSE: LCTX), Inc. (NYSE American and TASE: LCTX), a biotechnology firm specializing in cell therapies, has shared an update on its progress and future ...

Richmond School Board outlines disciplinary system for student cell phone use under new policies by: Ryan Nadeau. Posted: Dec 2, 2024 / 10:41 PM EST. Updated: Dec 2, 2024 / 11:16 PM EST.

Gov. Kathy Hochul said New York’s new cell phone ban for K-12 classrooms will improve mental health and learning as Long ...

This school year, South Sioux City High School is laying out its expectations when it comes to cell phones. Before class starts, students are expected to place their phones in a holder that can be ...

Horry County Schools is set to outline its proposed cellphone ban to be in line with a statewide ban taking effect in January. News.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Greg Kunst of Aurion Biotech provides an update on the company’s cell therapy for corneal endothelial disease.

Despite canceling the build-out of 7,000 small cells, Crown Castle said it remains on course to deliver 40,000 more small cells over the next few years, in addition to the 70,000 it already operates.

Lineage's allogeneic cell therapy program, OpRegen®, for treating dry-age related macular degeneration (dry-AMD), is currently in a Phase 2a clinical trial in collaboration with Roche and Genentech.